Metformin still best first-line oral hypoglycemic drug for type 2 diabetes

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
1,160
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Mar 15, 2011

NEW YORK (Reuters Health) -- An updated review of medications available for treating type 2 diabetes concludes that metformin continues to have the best benefit-to-harm profile, according to a report in the Annals of Internal Medicine online March 14.

For more information, please visit: http://www.thedoctorschannel.com/video/4166.html

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more